Abstract
INTRODUCTION
Traditional Chinese Medicine (TCM) characterizes the spleen as an organ of comprehensive function associated with a number of biological systems including the immune system. Spleen-deficiency pattern (SDP) is a group of symptoms and signs defined by TCM clinical practice in terms of its theory. SDP is one of the most commonly encountered patterns in TCM practice and often involves immune dysfunction as well as disorders of the digestive system. The occurrence and development of SDP is believed to have its own genomic basis. 1 Indeed, we previously showed that the differential gene profile of SDP patients (those with chronic gastritis and ulcerative colitis) was mainly associated with pathways of substance and energy metabolism and immune regulation, and that gene expression tended to be down-regulated compared with healthy controls. [2] [3] [4] [5] [6] These findings were also determined in a previous gene array study on peripheral white blood cells (PWBCs) from chronic gastritis and ulcerative colitis patients with SDP. 7 However, gene array studies on SDP have certain limitations, including a restriction of disease entities and tissue sources. SDP is recognized by TCM as one of the primary causes for the occurrence and development of type 2 diabetes mellitus (T2DM). 8, 9 Thus, the present study aimed to investigate the differential gene profile of PWBCs in T2DM-SDP patients to provide new insights into SDP clinical pattern differentiation.
MATERIALS AND METHODS

Recruitment of participants
Patients were included in the study if they met the following criteria: (a) were clinically diagnosed with T2DM (see below), (b) met the TCM pattern identified as SDP (see below), (c) were aged between 35 and 70 years, and (d) had signed the informed consent form. Exclusion criteria were as follows: (a) diagnosed with other endocrine diseases in addition to T2DM, or suffering severe complications caused by T2DM, (b) having infectious or inflammatory diseases, (c) having psychiatric or serious somatic diseases, (d) having dyslipidemia, and (e) pregnant or breastfeeding. The dominant symptoms are: (a) a pale tongue with a thin-white coating, (b) poor appetite, (c) abdominal distension, and (d) loose stools or diarrhea. The secondary symptoms are: (a) thinness, (b) weakness, and (c) a weak pulse. Possession of a pale tongue with a thin-white coating is essential for a diagnosis of SDP, and this should be combined with two of the other three dominant symptoms, or combined with one of the others and at least two of the secondary symptoms. Pattern differentiation was performed by two of the authors (Chen Longhui and Zhu Zhangzhi), and disagreement was resolved by discussion with Chen Weiwen. Healthy volunteers aged between 35 and 70 years were interviewed by one of the authors (Chen Ruifang). The volunteers were free of endocrine diseases including T2DM, infectious and inflammatory diseases, psychiatric and serious somatic diseases, and dyslipidemia. They also had no apparent TCM patterns, and a normal tongue and pulse. Those who did not sign the informed consent form were excluded from the study. We finally included 12 participants, of whom six were categorized as T2DM-SDP patients and six as healthy volunteers, from the First Affiliated Hospital of Guangzhou University of Chinese Medicine from October 2013 to December 2013. In the T2DM-SDP patients (three women and three men), the average age was 58.7 years (range, 48-67 years). In the healthy volunteers (three women and three men), the average age was 59.5 years (range, 50-65 years). No significant differences were observed between the two study groups regarding sex and age.
RNA isolation and quality control
Venous blood (> 3 mL) was collected from each fasting participant in the morning. EDTA (Beyotime Institute of Biotechnology, Shanghai, China) was introduced for anticoagulation. After separation, PWBCs were added to an appropriate volume of TRIzol (Invitrogen, Carlsbad, CA, USA) to achieve cell lysis. Total RNA was then isolated using the mirVana™ RNA Isolation Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. After quantification using a NanoDrop ND-2000 spectrophotometer (Thermo Scientific, Waltham, MA, USA), we used the Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) to detect the RNA Integrity Number (RIN) for RNA quality control.
Microarray Microarray experiments and screening of differentially expressed genes (DEGs) were conducted in the central laboratory of Shanghai OE Biotech Co., Ltd. (Shanghai, China). We used the Agilent SurePrint G3 Human Gene Expression 8 × 60k v2 Microarray kit (Design ID: 039494; Agilent Technologies, Shanghai, China), which included a chip that could simultaneously detect expression level changes of 30 000 protein-coding Entrez Gene RNAs and 12 000 long intergenic non-coding RNAs. Sample labeling, microarray hybridization, and washing were performed according to the manufacturer's instructions. Briefly, total RNA was transcribed to double-stranded cDNA, then synthesized into cRNA and labeled with cyanine 3-CTP. The labeled cRNAs were then hybridized onto the microarray. After washing, the arrays were scanned by the Agilent Scanner G2505C (Agilent Technologies).
Screening of differentially expressed genes
Feature Extraction software (version 10.7.1.1; Agilent Technologies, Shanghai, China) was used to analyze array images to obtain raw data. Raw data were normalized with the quantile algorithm, then GeneSpring software (version 12.5; Agilent Technologies, Shanghai, China) was used to complete the basic analysis. Probes that 100% of the values in at least one out of all conditions have flags in "Detected" were chosen for further data analysis. Genes that were differentially expressed between T2DM-SDP patients and healthy volunteers were identified through fold-changes as well as P values calculated using the t-test. The threshold for up-and down-regulated genes was a fold-change³ 2.0 and a P value ≤ 0.05. A negative value of fold-change was considered to represent a down-regulated gene, while a positive value represented an up-regulated gene.
Bioinformatics analysis of differentially expressed genes
Several free online databases, including GenBank, GeneCard, and DAVID, were used to annotate information about DEGs. We also performed Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs using the FunNet tool (www. funnet.info). The significance of gene enrichment of the considered KEGG category or annotation cluster was calculated using Fisher's exact test. A P value < 0.05 was considered significant. MeV version 4.6 software (Dana-Farber Cancer Institute, Boston, MA, USA) was used to perform hierarchical cluster analysis of DEGs to reveal distinguishable gene expression patterns between the two study groups.
RESULTS
RNA quality control
An Agilent Bioanalyzer 2100 was used to detect RIN for RNA quality control. We would discard those samples that failed to meet the standard of RIN ≥ 7.0 and 28 S / 18 S > 0.7. Fortunately, all RNA samples of the participants tested passed the strict quality control ( Figure 1 ).
Screening of differentially expressed genes between T2DM-SDP patients and healthy volunteers
The six healthy volunteers served as the control group. We screened genes expressed differentially between T2DM-SDP patients (1-6) and healthy volunteers (7) (8) (9) (10) (11) (12) . These findings were represented in a volcano plot (Figure 2) , in which the log2 (fold-change) is shown on the x-axis and the -log10 (P value) is shown on the y-axis. Both DEGs and differentially expressed non-coding RNAs (ncRNAs) are marked in red. A total of 175 DEGs were identified between the two study groups, of which 111 (63%) were down-regulated and 64 (37%) were up-regulated in T2DM-SDP patients compared with healthy volunteers. Of the 175 genes, 158 (90%) had biological function annotations. We also obtained 138 differentially expressed ncRNAs, of which 76 (55%) were down-regulated and 62 (45%) up-regulated in T2DM-SDP patients compared with healthy volunteers. None of the ncRNAs had biological function annotations, so they were not investigated further in the present study. 
Annotations of differentially expressed genes between T2DM-SDP patients and healthy volunteers
Among the 158 annotated genes, 46 (29%) were directly related to PWBC immune regulation or the immune response. Of these, 27 genes were down-regulated and the remaining 19 were up-regulated in T2DM-SDP patients compared with controls ( Table 1 ). The CCL23 protein demonstrates chemotactic activity for monocytes, resting T lymphocytes, and neutrophils. 13 Thus, the down-regulation (P = 0.0003, fold-change = -5.5459) of CCL23 might be responsible for the observed hypoimmunity of T2DM-SDP patients. We also identified 25 DEGs (16%) that were related to substance and energy metabolism of PWBCs, of which 18 were down-regulated and seven up-regulated in T2DM-SDP patients compared with controls (data not shown). These gene products could also indirectly influence the immunity of an individual. For example, the protein encoded by the prostaglandin-endoperoxide synthase 2 gene (PTGS2) mediates the formation of prostaglandins from arachidonate, and may have a role as a major mediator of inflammation. 14 Thus the down-regulation of PTGS2 (P = 0.0004, foldchange = -2.6323) in T2DM-SDP patients might also contribute to their immune dysfunction. The remaining 87 DEGs were shown to be involved in a wide variety of PWBC biological processes, including transcriptional regulation, DNA repair and replication, chromosomal stability and segregation, cell cycle progression, cell proliferation and differentiation, apoptosis, cell-cell communication, and cell motility (data not shown). Abnormal expression of these genes might also influence the immune functions of individuals.
KEGG pathway enrichment analysis of differentially expressed genes between T2DM-SDP patients and healthy volunteers
We next performed KEGG pathway enrichment analysis using the FunNet tool. As shown in Table 2 and Figure 3, DEGs were predominantly enriched in the following pathways: cytokine-cytokine receptor interaction (44.4% ), natural killer cell-mediated cytotoxicity (33.3%), chemokine signaling pathway (27.8%), antigen processing and presentation (27.8%), hematopoietic cell lineage (22.2%), complement and coagulation cascades (16.7% ), and graft-versus-host disease (16.7% ). All of these pathways are related to immune regulation or response. We also investigated the number of annotated genes with respect to KEGG category or annotation cluster, and found that most of the enriched genes were involved in immune regulation or response. Percentages show the ratio of the number of enriched genes to the number of available genes that could be enriched within the considered KEGG category or annotation cluster.
Hierarchical cluster analysis of differentially expressed genes between T2DM-SDP patients and healthy volunteers
We conducted hierarchical cluster analysis of the 175 DEGs between T2DM-SDP patients and healthy volunteers to show the distinguishable gene expression pattern between the two study groups. As shown in Figure  4 , the T2DM-SDP patient group (dia1-dia6) and healthy volunteer group (con1-con6) could be clustered into two separate categories, indicating the existence of different gene profiles. Thus the gene profiling could be applied for clinical pattern differentiation between T2DM-SDP patients and healthy volunteers. The clustering also revealed that the DEGs of T2DM-SDP patients tended to be down-regulated compared with expression in healthy volunteers, which is consistent with our previous SDP studies in chronic gastritis.
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DISCUSSION
Accumulating clinical evidence suggests that SDP patients usually manifest with hypoimmunity as well as dysfunction of the digestive system. White blood cells are recognized as the most important cells in innate and specific immunities, and a previous study investigating the differential gene profile of PWBCs in SDP patients with chronic gastritis and ulcerative colitis concluded that immune dysfunction was responsible for the occurrence and development of SDP. 7 Gene array studies on SDP are rare, and predominantly focused on digestive system disease. The present study introduced a non-digestive disease, T2DM, as the object of study in association with SDP for the first time, and collected PWBCs as the tissue source for gene array analysis. Our findings revealed differential gene profiles of PWBCs between T2DM-SDP patients and healthy volunteers. We screened a total of 175 DEGs, of which 111 (63%) were down-regulated and 64 (37%) up-regulat- Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5a
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Kruppel-like factor 6 Of the 158 genes with biological function annotations, 46 were directly related with immune regulation or response; 25 were associated with substance and energy metabolism, which could also indirectly influence immunity; and 87 were involved in a variety of processes that might influence immune functions. Moreover, KEGG pathway enrichment analysis of the DEGs found that they were predominantly enriched in immune-related pathways. Among the 46 DEGs directly related to immune regulation or response, 27 were down-regulated and participate in a wide variety of immune processes, including macrophage recruitment, 15 neutrophil and monocytemediated inflammatory responses, 16 chemotactic activity on immune cells, e.g. interleukin-8 activity, _EN-REF_11 13, 17 lymphocyte development and activation, 18 antigen capturing, 19 cytotoxic lymphocyte-mediated immunity, 20 and complement activation. The down-regulation of these genes could result in impairment of an individual's innate and specific immunity, thus contributing to the hypoimmunity of T2DM-SDP patients. The other 19 genes were up-regulated and are also involved in various immune processes, such as the migration of T-cell progenitors to the thymus, 21 B-cell migration and activation, 22 B-lymphocyte development and differentiation, and the response of B-cells to antigens. 23 The up-regulation of these genes might explain the immune dysfunction of T2DM-SDP patients. Together, these results suggest that the 46 DEGs are responsible for the hypoimmunity and / or immune dysfunction of T2DM-SDP patients observed in clinical practice. TCM patterns are considered to be pathological summaries of the etiology, location, nature, and tendency of diseases of certain stages. Moreover, the gene expression profile reflects current and specific characteristics of the organism, so it is reasonable to expect connections between these profiles and TCM patterns in the clinical diagnosis and classification of disease, as demonstrated in the current study.
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